WeVote
Log In

Bill

Bill

HD 2922

An Act relating to patient choice in dispensing of clinician-administered drugs

194th Legislature (2025-2026) Introduced by Lindsay Sabadosa

Massachusetts bill requires patients can choose where clinician-administered drugs are dispensed, expanding pharmacy selection beyond provider-restricted options.

0
WeVote Research Nonpartisan
Bill Summary · HD 2922

Legislative bill overview

HD 2922 would require that patients have the right to choose where they obtain clinician-administered drugs, rather than being restricted to a specific pharmacy or provider location. The bill aims to expand patient autonomy in selecting which pharmacy or facility dispenses medications prescribed by their clinician.

Why is this important

Patient choice in pharmacy selection can affect medication costs, convenience, and accessibility—particularly in areas with limited pharmacy options or for patients without preferred relationships with specific providers. This directly impacts consumers' out-of-pocket expenses and ability to use mail-order, specialty, or independent pharmacies rather than those tied to hospital systems or insurance networks.

Potential points of contention

  • Provider resistance: Clinicians and healthcare systems may argue that restricting where drugs are dispensed ensures proper monitoring, reduces medication errors, and maintains continuity of care
  • Insurance network concerns: Insurance companies may contend that directing patients to in-network pharmacies controls costs and prevents higher-priced alternatives from being selected
  • Specialty pharmacy complications: For complex medications requiring special handling or monitoring, concentrating dispensing at specific locations may provide legitimate clinical and safety advantages that patient choice could undermine

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.